Characterization of an F1 deletion mutant of Yersinia pestis CO92, pathogenic role of F1 antigen in bubonic and pneumonic plague, and evaluation of sensitivity and specificity of F1 antigen capture-based dipsticks

Journal of Clinical Microbiology

Volumn 49, Issue 5, 2011, Pages 1708-1715

  Sha, Jian ^a   Endsley, Janice J ^a,b   Kirtley, Michelle L ^a   Foltz, Sheri M ^a   Huante, Matthew B ^a   Erova, Tatiana E ^a   Kozlova, Elena V ^a   Popov, Vsevolod L ^a   Yeager, Linsey A ^a,b   Zudina, Irina V ^a   Motin, Vladimir L ^a,b   Peterson, Johnny W ^a,b   DeBord, Kristin L ^c   Chopra, Ashok K ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; F1 ANTIGEN; UNCLASSIFIED DRUG;

ACCURACY; ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN DETECTION; ANTIGEN PURIFICATION; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM DETECTION; BUBONIC PLAGUE; CONTROLLED STUDY; DELETION MUTANT; F1 ANTIGEN CAPTURED DIPSTICK; FEMALE; GROWTH RATE; MOUSE; NONHUMAN; PATHOGENICITY; PLAGUE; PNEUMONIC PLAGUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TEMPERATURE; YERSINIA PESTIS;

ANIMALS; BACTERIAL PROTEINS; CLINICAL LABORATORY TECHNIQUES; DISEASE MODELS, ANIMAL; FEMALE; GENE DELETION; IMMUNOASSAY; MICE; MICE, INBRED BALB C; PLAGUE; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; VIRULENCE; VIRULENCE FACTORS; YERSINIA PESTIS;

BACILLI (CLASS); BACTERIA (MICROORGANISMS); MUS; YERSINIA PESTIS;

EID: 79955526113     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00064-11     Document Type: Article

References (56)

1. Abramov, V. M., et al. 2002. Structural and functional properties of Yersinia pestis Caf1 capsular antigen and their possible role in fulminant development of primary pneumonic plague. J. Proteome Res. 1:307-315.
2. Abramov, V. M., et al. 2001. Structural and functional similarity between Yersinia pestis capsular protein Caf1 and human interleukin-1 beta. Biochemistry 40:6076-6084.
3. Baker, E. E., H. Sommer, L. E. Foster, E. Meyer, and K. F. Meyer. 1952. Studies on immunization against plague. I. The isolation and characterization of the soluble antigen of Pasteurella pestis. J. Immunol. 68:131-145.
4. Brubaker, R. R. 1970. Interconversion of purine mononucleotides in Pasteurella pestis. Infect. Immun. 1:446-454.
5. Burrows, T. W. 1957. Virulence of Pasteurella pestis. Nature 179:1246-1247.
6. Burrows, T. W., and G. A. Bacon. 1956. The basis of virulence in Pasteurella pestis: the development of resistance to phagocytosis in vitro. Br. J. Exp. Pathol. 37:286-299.
7. Cavanaugh, D. C., and R. Randall. 1959. The role of multiplication of Pasteurella pestis in mononuclear phagocytes in the pathogenesis of fleaborne plague. J. Immunol. 83:348-363.
8. Chanteau, S., et al. 1998. F1 antigenaemia in bubonic plague patients, a marker of gravity and efficacy of therapy. Trans. R. Soc. Trop. Med. Hyg. 92:572-573.
9. Chanteau, S., et al. 2003. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet 361:211-216. (Pubitemid 36126221)
10. Chanteau, S., et al. 2000. Early diagnosis of bubonic plague using F1 antigen capture ELISA assay and rapid immunogold dipstick. Int. J. Med. Microbiol. 290:279-283.
11. Datsenko, K. A., and B. L. Wanner. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645.
12. Davis, K. J., et al. 1996. Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops). Arch. Pathol. Lab. Med. 120: 156-163.
13. Dennis, D. T., and M. C. Chu. 2003. A major new test for plague. Lancet 361:191-192.
14. Doll, J. M., et al. 1994. Cat-transmitted fatal pneumonic plague in a person who traveled from Colorado to Arizona. Am. J. Trop. Med. Hyg. 51:109-114.
15. Donavan, J. E., D. Ham, G. M. Fukui, and M. J. Surgalla. 1961. Role of the capsule of Pasteurella pestis in bubonic plague in the guinea pig. J. Infect. Dis. 109:154-157.
16. Drozdov, I. G., et al. 1995. Virulent non-capsulate Yersinia pestis variants constructed by insertion mutagenesis. J. Med. Microbiol. 42:264-268.
17. Du, Y., R. Rosqvist, and A. Forsberg. 2002. Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis. Infect. Immun. 70:1453-1460.
18. Friedlander, A. M., et al. 1995. Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis. Clin. Infect. Dis. 21(Suppl. 2):S178-S181.
19. Hamad, M. A., and M. L. Nilles. 2007. Roles of YopN, LcrG and LcrV in controlling Yops secretion by Yersinia pestis. Adv. Exp. Med. Biol. 603: 225-234.
20. Hinnebusch, J., and T. G. Schwan. 1993. New method for plague surveillance using polymerase chain reaction to detect Yersinia pestis in fleas. J. Clin. Microbiol. 31:1511-1514.
21. Inglesby, T. V., et al. 2000. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 283: 2281-2290. (Pubitemid 30246781)
22. Jonas, D., et al. 2000. Comparative evaluation of three different genotyping methods for investigation of nosocomial outbreaks of Legionnaires' disease in hospitals. J. Clin. Microbiol. 38:2284-2291.
23. Kingston, R., et al. 2007. The fraction 1 and V protein antigens of Yersinia pestis activate dendritic cells to induce primary T cell responses. Clin. Exp. Immunol. 149:561-569.
24. Koornhof, H. J., R. A. Smego, Jr., and M. Nicol. 1999. Yersiniosis. II. The pathogenesis of Yersinia infections. Eur. J. Clin. Microbiol. Infect. Dis. 18: 87-112.
25. Krakauer, T., and D. Heath. 1998. Lack of IL-1 receptor antagonistic activity of the capsular F1 antigen of Yersinia pestis. Immunol. Lett. 60:137-142.
26. Lathem, W. W., P. A. Price, V. L. Miller, and W. E. Goldman. 2007. A plasminogen-activating protease specifically controls the development of primary pneumonic plague. Science 315:509-513.
27. MacIntyre, S., S. D. Knight, and L. J. Fooks. 2004. Structure, assembly and applications of the polymeric F1 antigen of Yersinia pestis, p. 363-408. In E. C. B. J. Hinnebusch (ed.), Yersinia molecular and cellular biology. Horizon Sciences, Norfolk, United Kingdom.
28. MacIntyre, S., et al. 2001. An extended hydrophobic interactive surface of Yersinia pestis Caf1M chaperone is essential for subunit binding and F1 capsule assembly. Mol. Microbiol. 39:12-25.
29. Neubauer, H., et al. 2000. A combination of different polymerase chain reaction (PCR) assays for the presumptive identification of Yersinia pestis. J. Vet. Med. B Infect. Dis. Vet. Public Health 47:573-580.
30. Neubauer, H., et al. 2000. Serodiagnosis of human plague by an anti-F1 capsular antigen specific IgG/IgM ELISA and immunoblot. Epidemiol. Infect. 125:593-597.
31. Norkina, O. V., et al. 1994. Development of a diagnostic test for Yersinia pestis by the polymerase chain reaction. J. Appl. Bacteriol. 76:240-245.
32. Phillips, A. P., B. C. Morris, D. Hall, M. Glenister, and J. E. Williams. 1988. Identification of encapsulated and non-encapsulated Yersinia pestis by immunofluorescence tests using polyclonal and monoclonal antibodies. Epidemiol. Infect. 101:59-73.
33. Pujol, C., and J. B. Bliska. 2005. Turning Yersinia pathogenesis outside in: subversion of macrophage function by intracellular yersiniae. Clin. Immunol. 114:216-226.
34. Rahalison, L., E. Vololonirina, M. Ratsitorahina, and S. Chanteau. 2000. Diagnosis of bubonic plague by PCR in Madagascar under field conditions. J. Clin. Microbiol. 38:260-263.
35. Ratsitorahina, M., S. Chanteau, L. Rahalison, L. Ratsifasoamanana, and P. Boisier. 2000. Epidemiological and diagnostic aspects of the outbreak of pneumonic plague in Madagascar. Lancet 355:111-113. (Pubitemid 30068556)
36. Runco, L. M., S. Myrczek, J. B. Bliska, and D. G. Thanassi. 2008. Biogenesis of the fraction 1 capsule and analysis of the ultrastructure of Yersinia pestis. J. Bacteriol. 190:3381-3385.
37. Russell, P., et al. 1997. Laboratory diagnosis of plague. Br. J. Biomed. Sci. 54:231-236.
38. Sebbane, F., C. Jarrett, D. Gardner, D. Long, and B. J. Hinnebusch. 2009. The Yersinia pestis caf1M1A1 fimbrial capsule operon promotes transmission by flea bite in a mouse model of bubonic plague. Infect. Immun. 77:1222-1229.
39. Sebbane, F., et al. 2006. Adaptive response of Yersinia pestis to extracellular effectors of innate immunity during bubonic plague. Proc. Natl. Acad. Sci. U. S. A. 103:11766-11771.
40. Sha, J., et al. 2008. Braun lipoprotein (Lpp) contributes to virulence of yersiniae: potential role of Lpp in inducing bubonic and pneumonic plague. Infect. Immun. 76:1390-1409.
41. Sharma, R. K., A. Sodhi, and H. V. Batra. 2005. Involvement of c-Jun N-terminal kinase in rF1 mediated activation of murine peritoneal macrophages in vitro. J. Clin. Immunol. 25:215-223.
42. Sharma, R. K., A. Sodhi, H. V. Batra, and U. Tuteja. 2005. Phosphorylation of p42/44 MAP kinase is required for rF1-induced activation of murine peritoneal macrophages. Mol. Immunol. 42:1385-1392.
43. Sodhi, A., R. K. Sharma, H. V. Batra, and U. Tuteja. 2004. Recombinant fraction 1 protein of Yersinia pestis activates murine peritoneal macrophages in vitro. Cell Immunol. 229:52-61. (Pubitemid 39141135)
44. Splettstoesser, W. D., L. Rahalison, R. Grunow, H. Neubauer, and S. Chanteau. 2004. Evaluation of a standardized F1 capsular antigen capture ELISA test kit for the rapid diagnosis of plague. FEMS Immunol. Med. Microbiol. 41:149-155.
45. Thullier, P., V. Guglielmo, M. Rajerison, and S. Chanteau. 2003. Short report: serodiagnosis of plague in humans and rats using a rapid test. Am. J. Trop. Med. Hyg. 69:450-451.
46. Tomaso, H., et al. 2007. Comparison of hand-held test kits, immunofluorescence microscopy, enzyme-linked immunosorbent assay, and flow cytometric analysis for rapid presumptive identification of Yersinia pestis. J. Clin. Microbiol. 45:3404-3407.
47. Welkos, S. L., G. P. Andrews, L. E. Lindler, N. J. Snellings, and S. D. Strachan. 2004. Mu dI1(Ap lac) mutagenesis of Yersinia pestis plasmid pFra and identification of temperature-regulated loci associated with virulence. Plasmid 51:1-11.
48. WHO. 2000. Human plague in 1998 and 1999. Wkly. Epidemiol. Rec. 75: 338-339.
49. Williams, J. E., and D. C. Cavanaugh. 1983. Chronic infections in laboratory rodents from inoculation of nonencapsulated plague bacilli (Yersinia pestis). Experientia 39:408-409.
50. Williams, J. E., and D. C. Cavanaugh. 1984. Potential for rat plague from nonencapsulated variants of the plague bacillus (Yersinia pestis). Experientia 40:739-740.
51. Williams, J. E., M. K. Gentry, C. A. Braden, F. Leister, and R. H. Yolken. 1984. Use of an enzyme-linked immunosorbent assay to measure antigenaemia during acute plague. Bull. World Health Organ. 62:463-466.
52. Williams, R. C., Jr., H. Gewurz, and P. G. Quie. 1972. Effects of fraction I from Yersinia pestis on phagocytosis in vitro. J. Infect. Dis. 126:235-241.
53. Winter, C. C., W. B. Cherry, and M. D. Moody. 1960. An unusual strain of Pasteurella pestis isolated from a fatal human case of plague. Bull. World Health Organ. 23:408-409.
54. Zavialov, A. V., et al. 2003. Structure and biogenesis of the capsular F1 antigen from Yersinia pestis: preserved folding energy drives fiber formation. Cell 113:587-596. (Pubitemid 36694184)
55. Zavialov, A. V., et al. 2002. Donor strand complementation mechanism in the biogenesis of non-pilus systems. Mol. Microbiol. 45:983-995.
56. Zav'yalov, V. P., et al. 1995. Specific high affinity binding of human interleukin 1 beta by Caf1A usher protein of Yersinia pestis. FEBS Lett. 371: 65-68.